StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) stock

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.36−0.05 (-3.87%)

Close on Nov 17, 2026Market cap $34.67MP/E –Yield –

Serina Therapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Serina Therapeutics's operating income for the twelve months ending Dec 31, 2025 was -$24.02M. For fiscal 2025 it was -$24.02M. The highest annual figure on record is -$3.13M in fiscal 2023.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$24.02M–
FY2024Dec 31, 2024-$17.05M–
FY2023Dec 31, 2023-$3.13M–
FY2022Dec 31, 2022-$6.98M–
FY2021Dec 31, 2021-$7.93M–
FY2020Dec 31, 2020-$10.10M–
FY2019Dec 31, 2019-$12.56M–
FY2018Dec 31, 2018-$11.25M–
FY2017Dec 31, 2017-$6.66M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.78M–
Q4 FY2025Dec 31, 2025-$6.21M–
Q3 FY2025Sep 30, 2025-$6.39M–
Q2 FY2025Jun 30, 2025-$5.57M–
Q1 FY2025Mar 31, 2025-$5.86M–
Q4 FY2024Dec 31, 2024-$5.55M-2402.5%
Q3 FY2024Sep 30, 2024-$5.31M–
Q2 FY2024Jun 30, 2024-$3.87M–
Q1 FY2024Mar 31, 2024-$2.32M–
Q4 FY2023Dec 31, 2023$241.00K–
Q3 FY2023Sep 30, 2023-$1.46M–
Q2 FY2023Jun 30, 2023-$945.00K–
Q1 FY2023Mar 31, 2023-$962.00K–
Q4 FY2022Dec 31, 2022-$1.78M–
Q3 FY2022Sep 30, 2022-$1.55M–
Q2 FY2022Jun 30, 2022-$1.59M–
Q1 FY2022Mar 31, 2022-$2.05M–
Q4 FY2021Dec 31, 2021-$1.87M–
Q3 FY2021Sep 30, 2021-$1.67M–
Q2 FY2021Jun 30, 2021-$2.21M–
Q1 FY2021Mar 31, 2021-$2.19M–
Q4 FY2020Dec 31, 2020-$2.33M–
Q3 FY2020Sep 30, 2020-$2.40M–
Q2 FY2020Jun 30, 2020-$2.37M–
Q1 FY2020Mar 31, 2020-$3.01M–
Q4 FY2019Dec 31, 2019-$2.72M–
Q3 FY2019Sep 30, 2019-$3.28M–
Q2 FY2019Jun 30, 2019-$3.44M–
Q1 FY2019Mar 31, 2019-$3.12M–
Q4 FY2018Dec 31, 2018-$3.36M–
Q3 FY2018Sep 30, 2018-$2.20M–
Q2 FY2018Jun 30, 2018-$2.13M–
Q1 FY2018Mar 31, 2018-$3.55M–

More Serina Therapeutics figures

See a number that looks wrong?